Orsini
Overview
Independent rare disease and gene therapy specialty pharmacy that also offers hub services, home infusion nursing, and 3PL support for complex product launches. Primarily a specialty pharmacy (dual-role vendor) with integrated patient services for manufacturers.
Notable
Acquired by Carlyle Group and Consonance Capital in 2022; accreditations include URAC, ACHC (Rare Disease Distinction), and The Joint Commission.
Key services
- specialty pharmacy dispensing
- hub and patient support services
- benefit investigation
- home infusion nursing
- 3PL distribution
Subcategories
Verified Reviews
No verified reviews yet — are you a customer of Orsini? Share your experience in a short, confidential interview.
Share your experience